USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 152 filers reported holding USANA HEALTH SCIENCES INC in Q4 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $27,958 | +2.8% | 618 | +10.2% | 0.00% | – |
Q1 2024 | $27,209 | -5.3% | 561 | +4.7% | 0.00% | – |
Q4 2023 | $28,730 | -4.2% | 536 | +3.5% | 0.00% | – |
Q3 2023 | $30,000 | -6.2% | 518 | +0.6% | 0.00% | – |
Q2 2023 | $32,000 | 0.0% | 515 | 0.0% | 0.00% | – |
Q1 2023 | $32,000 | +28.0% | 515 | +9.1% | 0.00% | – |
Q4 2022 | $25,000 | -65.3% | 472 | -63.2% | 0.00% | – |
Q3 2022 | $72,000 | -13.3% | 1,284 | +11.7% | 0.00% | – |
Q2 2022 | $83,000 | +1.2% | 1,149 | +11.7% | 0.00% | – |
Q1 2022 | $82,000 | -14.6% | 1,029 | +8.9% | 0.00% | – |
Q4 2021 | $96,000 | +9.1% | 945 | -0.9% | 0.00% | – |
Q3 2021 | $88,000 | -5.4% | 954 | +5.5% | 0.00% | – |
Q2 2021 | $93,000 | +16.2% | 904 | +10.0% | 0.00% | – |
Q1 2021 | $80,000 | +23.1% | 822 | -2.4% | 0.00% | – |
Q4 2020 | $65,000 | +8.3% | 842 | +3.6% | 0.00% | – |
Q3 2020 | $60,000 | 0.0% | 813 | -1.0% | 0.00% | – |
Q2 2020 | $60,000 | +17.6% | 821 | -6.8% | 0.00% | – |
Q1 2020 | $51,000 | -12.1% | 881 | +19.2% | 0.00% | – |
Q4 2019 | $58,000 | -94.0% | 739 | -94.7% | 0.00% | -100.0% |
Q3 2019 | $960,000 | +24.5% | 14,033 | +44.5% | 0.01% | +25.0% |
Q2 2019 | $771,000 | -30.5% | 9,709 | -26.6% | 0.00% | -33.3% |
Q1 2019 | $1,109,000 | -28.8% | 13,225 | 0.0% | 0.01% | -33.3% |
Q4 2018 | $1,557,000 | -6.0% | 13,225 | -3.8% | 0.01% | +12.5% |
Q3 2018 | $1,657,000 | -5.0% | 13,745 | -9.2% | 0.01% | -11.1% |
Q2 2018 | $1,745,000 | +82.5% | 15,138 | +36.1% | 0.01% | +80.0% |
Q1 2018 | $956,000 | +15.3% | 11,125 | -0.7% | 0.01% | +25.0% |
Q4 2017 | $829,000 | +9.7% | 11,198 | -14.5% | 0.00% | 0.0% |
Q3 2017 | $756,000 | -45.8% | 13,103 | -39.9% | 0.00% | 0.0% |
Q2 2017 | $1,396,000 | +113.8% | 21,794 | +92.3% | 0.00% | 0.0% |
Q1 2017 | $653,000 | -7.5% | 11,334 | -4.9% | 0.00% | 0.0% |
Q4 2016 | $706,000 | -14.4% | 11,922 | +100.0% | 0.00% | -20.0% |
Q3 2016 | $825,000 | +24.2% | 5,961 | 0.0% | 0.01% | +25.0% |
Q2 2016 | $664,000 | -8.3% | 5,961 | 0.0% | 0.00% | -20.0% |
Q1 2016 | $724,000 | -5.0% | 5,961 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $762,000 | -4.6% | 5,961 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $799,000 | – | 5,961 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |